About: Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients
Creator	Diehl, Jean-Luc Boussier, Jeremy Charbit, Bruno Debuc, Benjamin Duffy, Darragh Goudot, Guillaume Hadjadj, Jérôme Hauw-Berlemont, Caroline Mirault, Tristan Smadja, David Terrier, Benjamin Augy, Jean-Loup Chocron, · Gaussem, · Gendron, Nicolas Guerin, Coralie Juvin, Philippe Khider, Lina Messas, · Peron, Nicolas Planquette, · Sanchez, · Yatim, ·
Source	Medline; PMC
abstract	BACKGROUND: Coronavirus disease-2019 (COVID-19), a respiratory disease has been associated with ischemic complications, coagulation disorders, and an endotheliitis. OBJECTIVES: To explore endothelial damage and activation-related biomarkers in COVID-19 patients with criteria of hospitalization for referral to intensive care unit (ICU) and/or respiratory worsening. METHODS: Analysis of endothelial and angiogenic soluble markers in plasma from patients at admission. RESULTS: Study enrolled 40 consecutive COVID-19 patients admitted to emergency department that fulfilled criteria for hospitalization. Half of them were admitted in conventional wards without any ICU transfer during hospitalization; whereas the 20 others were directly transferred to ICU. Patients transferred in ICU were more likely to have lymphopenia, decreased SpO2 and increased D-dimer, CRP and creatinine levels. In those patients, soluble E-selectin and angiopoietin-2 were significantly increased (p value at 0.009 and 0.003, respectively). Increase in SELE gene expression (gene coding for E-selectin protein) was confirmed in an independent cohort of 32 patients using a whole blood gene expression profile analysis. In plasma, we found a strong association between angiopoetin-2 and CRP, creatinine and D-dimers (with p value at 0.001, 0.001 and 0.003, respectively). ROC curve analysis identified an Angiopoietin-2 cut-off of 5000 pg/mL as the best predictor for ICU outcome (Se = 80.1%, Sp = 70%, PPV = 72.7%, NPV = 77%), further confirmed in multivariate analysis after adjustment for creatinine, CRP or D-dimers. CONCLUSION: Angiopoietin-2 is a relevant predictive factor for ICU direct admission in COVID-19 patients. This result showing an endothelial activation reinforces the hypothesis of a COVID-19-associated microvascular dysfunction.
has issue date	2020-05-27(xsd:dateTime)
bibo:doi	10.1007/s10456-020-09730-0
bibo:pmid	32458111
has license	no-cc
sha1sum (hex)	ab5e3a99004517d2fd913dc394b91897b71f0b61
schema:url	https://doi.org/10.1007/s10456-020-09730-0
resource representing a document's title	Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients
has PubMed Central identifier	PMC7250589
has PubMed identifier	32458111
schema:publication	Angiogenesis
resource representing a document's body	covid:ab5e3a99004517d2fd913dc394b91897b71f0b61#body_text
is schema:about of	named entity 'NPV' named entity 'independent' named entity 'PPV' named entity 'ICU' named entity 'angiopoietin-2' named entity 'protein' named entity 'microvascular' named entity 'biomarkers' named entity 'E-selectin' named entity 'SpO2' named entity 'endothelial activation' named entity 'disorders' named entity 'transfer' named entity 'E-selectin' named entity 'angiogenesis' named entity 'ICU' named entity 'Platelet' named entity 'R Foundation' named entity 'heparin' named entity 'nasopharyngeal swabs' named entity 'selectin' named entity 'leukocytes' named entity 'lung compliance' named entity 'endoglin' named entity 'Angiopoietin-2' named entity 'FGF' named entity 'clinical evaluation' named entity 'endothelial cells' named entity 'EDTA' named entity 'mechanical ventilation' named entity 'ICU' named entity 'E-selectin' named entity 'creatinine' named entity 'ICU' named entity 'infection' named entity 'cardiovascular risk factors' named entity 'selectin' named entity 'E-selectin' named entity 'soluble' named entity 'plasma' named entity 'COVID-19' named entity 'blood' named entity 'plasma' named entity 'levels' named entity 'result' named entity 'endothelial activation' named entity 'angiogenic' named entity 'GUSB' named entity 'ARDS' named entity 'dimers' named entity 'Angiopoietin-2' named entity 'CRP' named entity 'cut-off' named entity 'endothelial dysfunction' named entity 'endothelial' named entity 'endothelial' named entity 'ICU' named entity 'COVID-19' named entity 'biomarker'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software